New research, funded by the British Heart Foundation, has found that a blood test for the C-reactive protein could help to identify those patients at a high risk of dying within three years after a heart attack.
Treatment plans could be developed accordingly, potentially saving lives.
The research, carried out by the National Heart and Lung Institute with the National Institute for Health Research Health Informatics Collaborative, was based on data from over 250,000 patients who had been admitted to hospital with a suspected heart attack.
Professor James Leiper, Associate Medical Director of BHF, is quoted as observing that “by better identifying which people are most at risk, this simple blood test could help to direct anti-inflammatory treatments to those who most need it.”
The British Heart Foundation estimates that approximately 160,000 deaths in the UK each year are due to heart and circulatory problems.
Speak to a legal expert
If you or a loved one are struggling with the impact of a significant failing in medical care, contact Glynns Solicitors to talk to an expert medical negligence solicitor
Please call us on 0800 234 3300 (or from a mobile 01275 334030) or complete our Online Enquiry Form.
Share Article With:
|
|
|
|
|
|
